drugset / Trial / NCT00366483

Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects

NCT00366483

Phase 1 Completed 40 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the safety, tolerability and pharmacokinetics of single and multiple ascending oral doses of lecozotan SR in healthy young and elderly subjects.

Timeline

Start
2006-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Lecozotan Small molecule Oral

Indications